Influence of Driver Mutations on Response to Ropeginterferon Alpha-2b in Patients with PV


Joe Scandura, MD, PhD, explains how a patient with polycythemia vera and driver mutations responds to interferon treatment.

Related Videos
Experts in oncology
Experts in oncology
Uwe Platzbecker, MD, an expert on myelodysplastic syndrome
Experts on myelodysplastic syndrome
Amy W. Zhou, MD
Experts on GVHD
Experts on FL
Related Content